title: Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
abstract: OBJECTIVE
  Cadherins and their associated molecules, such as alpha-catenin, have been shown recently to play a pivotal role in epithelial carcinogenesis.
  
  
  METHODS
  The expression of E-cadherin, N-cadherin, and alpha-catenin in 10 normal samples, 28 focal nodular hyperplasias, 9 liver cell adenomas, 65 hepatocellular carcinomas, and 9 cholangiocarcinomas was studied by immunohistochemistry and Western blotting.
  
  
  RESULTS
  In the normal liver, hepatocytes expressed E-cadherin and a 129-kilodalton cadherin identified by the anti-N-cadherin antibody GC4. The expression level of alpha-catenin was low. Bile duct cells expressed only E-cadherin and showed high levels of alpha-catenin. The expression of cadherins and alpha-catenin was preserved in focal nodular hyperplasia. In liver cell adenomas, cadherins and alpha-catenin were heterogeneously expressed. In hepatocellular carcinomas, cadherin and alpha-catenin expression was frequently reduced or absent. Alterations in cadherin expression correlated with large tumor size, low grade of histological differentiation, and occurrence of capsular and vascular invasion. In cholangiocarcinomas, neoplastic cells inconstantly expressed E-cadherin and alpha-catenin.
  
  
  CONCLUSIONS
  Alterations of cadherin and alpha-catenin expression are frequent in liver cell adenomas and primary liver carcinomas. Their incidence in hepatocellular carcinomas is of prognostic significance.
authors.affiliation: Laboratoire de Biologie Cellulaire, Faculté de Médecine Xavier Bichat, Université Paris, France.
authors.forename: R
authors.initials: R
authors.lastname: Kozyraki
authors.forename: J Y
authors.initials: JY
authors.lastname: Scoazec
authors.forename: J F
authors.initials: JF
authors.lastname: Flejou
authors.forename: A
authors.initials: A
authors.lastname: D'Errico
authors.forename: P
authors.initials: P
authors.lastname: Bedossa
authors.forename: B
authors.initials: B
authors.lastname: Terris
authors.forename: M
authors.initials: M
authors.lastname: Fiorentino
authors.forename: A F
authors.initials: AF
authors.lastname: Bringuier
authors.forename: W F
authors.initials: WF
authors.lastname: Grigioni
authors.forename: G
authors.initials: G
authors.lastname: Feldmann
mesh_terms: D018248:Adenoma, Liver Cell / Q000378:metabolism / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000368:Aged; D001650:Bile Duct Neoplasms / Q000378:metabolism / Q000473:pathology; D001653:Bile Ducts, Intrahepatic; D015153:Blotting, Western; D015820:Cadherins / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000473:pathology; D016009:Chi-Square Distribution; D018281:Cholangiocarcinoma / Q000378:metabolism / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011379:Prognosis; D051178:alpha Catenin
chemical_list: C495273:CTNNA1 protein, human; D015820:Cadherins; D003598:Cytoskeletal Proteins; D051178:alpha Catenin